These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 14737093

  • 1. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
    Stabile LP, Lyker JS, Huang L, Siegfried JM.
    Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
    [Abstract] [Full Text] [Related]

  • 2. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
    To C, Seiden I, Liu N, Wigle D, Tsao MS.
    Exp Cell Res; 2002 Feb 01; 273(1):45-53. PubMed ID: 11795945
    [Abstract] [Full Text] [Related]

  • 3. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 4. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H, Hung W, Tremblay E, Wojcik J, Gui J, Ho J, Klassen J, Campling B, Elliott B.
    J Cell Biochem; 2002 Jun 05; 86(4):665-77. PubMed ID: 12210733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B, Xia S, Abounader R, Laterra J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633
    [Abstract] [Full Text] [Related]

  • 11. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 15; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 12. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R, Eguchi K, Takahashi M, Goldman S, Okano H, Kawase T, Yazaki T.
    J Gene Med; 2006 Nov 15; 8(11):1329-40. PubMed ID: 16955534
    [Abstract] [Full Text] [Related]

  • 13. [c-Met and HGF expression in non-small-cell lung carcinomas].
    Korobko IV, Zinov'eva MV, Allakhverdiev AK, Zborovskaia IB, Svwrdlov ED.
    Mol Gen Mikrobiol Virusol; 2007 Nov 15; (2):18-21. PubMed ID: 17598453
    [Abstract] [Full Text] [Related]

  • 14. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282
    [Abstract] [Full Text] [Related]

  • 15. Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.
    Long IS, Han K, Li M, Shirasawa S, Sasazuki T, Johnston M, Tsao MS.
    Mol Cancer Res; 2003 Mar 15; 1(5):393-401. PubMed ID: 12651912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R.
    Cancer Res; 2003 Oct 01; 63(19):6272-81. PubMed ID: 14559814
    [Abstract] [Full Text] [Related]

  • 20. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
    Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S.
    Int J Oncol; 2007 Aug 01; 31(2):451-60. PubMed ID: 17611703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.